Human trials for the first ever HIV vaccine will start this year

The serum, developed in Oregon, cleared 60 percent of rhesus macques of SIV, the monkey version of HIV. 75 percent of those exposed to SIV again were resistant for three years.

Source: the Mail online | Health - July 17, 2019 Category: Consumer Health News Source Type: news